Neurogenetics
Neurogenetics delves into how genetic factors impact neurological disorders such as Alzheimer's disease and dementia. In Alzheimer's, mutations in genes like APP, PSEN1, and PSEN2 heighten vulnerability by disrupting amyloid-beta processing and tau protein regulation. Meanwhile, dementia, encompassing various forms of cognitive decline, also shows genetic links, notably with the APOE gene variant ε4 increasing the risk of late-onset Alzheimer's. Studying these genetic nuances is crucial for early detection and personalized treatment approaches. Unraveling these genetic foundations not only deepens our understanding of disease mechanisms but also paves the way for tailored therapies and preventive strategies in the future.
Committee Members
Jun Hua
Johns Hopkins University , United States
Nazneen N Dewji
Cenna Biosciences Inc, United States
Jacqueline London
Paris Diderot University, FranceSubmit your abstract Today
Title : Make a difference
Jacqueline Tuppen, Dementia UK, United Kingdom
Title : Imaging brain clearance in Alzheimer’s disease
Jun Hua, Johns Hopkins University , United States
Title : Neuromodulation of scalp electroacupuncture in the treatment of autism spectrum disorder
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Title : Neuroimaging-based evaluation of scalp acupuncture for neural repair and reorganization in children with cerebral palsy
Zhenhuan Liu, Nanhai Maternity and Children Hospital Affiliated to Guangzhou University of Chinese Medicine, China
Title : Neurophysiological change and cognitive response to levetiracetam in Alzheimer disease: Testing the missing mechanistic link
Christopher Hubler, Emergent Neural Systems Institute for Research, United States
Title : Healthcare professionals in Somaliland had low levels of knowledge and attitudes towards dementia care: A pilot survey
Mohamed Abdilahi Duale, Frantz Fanon University, Somalia